FIMI Philips, Matrox enhance PACS viewing capabilities

TriMed Staff | | Health Imaging | Diagnostic Imaging
FIMI Philips and Matrox Graphics Inc. have collaborated to introduce FIMI's SmartPivot display technology in its PACS range of LCD monitors for the medical imaging market. FIMI Philips is already bundling the Matrox MED Series 10-bit display controller boards with its new displays.

The companies said the new technology will be demonstrated at next week's Radiological Society of North America meeting, Nov. 28 - Dec. 2, in Chicago.

"SmartPivot enables easy display orientation, and features "smart" technology, which allows our new FIMI panel to communicate with the Matrox board to determine and set orientation automatically," says Franco Martegani, general manager, FIMI Philips.
  
"Matrox is pleased to have collaborated with FIMI Philips on this project, further enhancing the viewing abilities for medical imaging professionals using Matrox MED Series boards," said George Rigas, medical product manger, Matrox. "The new SmartPivot functionality provides medical imaging professionals with added ease-of-use and features to aid in their everyday tasks."

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup